Financial Ratios

MOREPEN LABORATORIES LTD.

NSE : MOREPENLABBSE : 500288ISIN CODE : INE083A01026Industry : Pharmaceuticals & DrugsHouse : Morepen
BSE62.70-0.8 (-1.26 %)
PREV CLOSE ( ) 63.50
OPEN PRICE ( ) 62.91
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 210606
TODAY'S LOW / HIGH ( )62.50 64.26
52 WK LOW / HIGH ( )41.66 100.8
NSE62.67-0.8 (-1.26 %)
PREV CLOSE( ) 63.47
OPEN PRICE ( ) 63.00
BID PRICE (QTY) 62.67 (50)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1983956
TODAY'S LOW / HIGH( ) 62.50 64.30
52 WK LOW / HIGH ( )42 100.9
Select year
ParticularsMar2024Mar2023Mar2022Mar2021Mar2020
Operational & Financial Ratios
   Earnings Per Share (Rs)2.170.902.122.100.72
   CEPS(Rs)2.601.262.562.721.48
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)17.3915.2611.978.926.83
   Tax Rate(%)25.5326.6519.500.0013.74
Margin Ratios
   Core EBITDA Margin(%)10.525.778.9110.108.14
   EBIT Margin(%)9.924.868.838.634.98
   Pre Tax Margin(%)9.694.718.668.474.73
   PAT Margin (%)7.213.456.978.474.08
   Cash Profit Margin (%)8.644.808.4411.008.43
Performance Ratios
   ROA(%)9.304.3210.7512.495.05
   ROE(%)13.296.8420.7726.6111.06
   ROCE(%)17.719.1523.7324.5410.82
   Asset Turnover(x)1.291.251.541.471.24
   Sales/Fixed Asset(x)3.112.702.911.921.12
   Working Capital/Sales(x)3.143.045.299.5041.95
Efficiency Ratios
   Fixed Capital/Sales(x)0.320.370.340.520.90
   Receivable days67.9365.0747.5245.4356.08
   Inventory Days51.2264.0153.8849.5651.46
   Payable days96.9392.6981.1292.58118.01
Valuation Parameters
   PER(x)19.3828.3917.3015.3413.27
   PCE(x)16.1820.4314.3011.826.43
   Price/Book(x)2.421.683.063.601.40
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)1.380.961.191.260.51
   EV/Core EBITDA(x)12.2015.4411.5411.255.47
   EV/EBIT(x)13.9519.7113.4514.5410.25
   EV/CE(x)2.321.591.671.650.61
   M Cap / Sales1.400.981.211.300.54
Growth Ratio
   Net Sales Growth(%)14.84-7.6230.2840.4610.42
   Core EBITDA Growth(%)110.03-44.3420.1568.037.56
   EBIT Growth(%)134.51-49.1933.25143.4428.56
   PAT Growth(%)139.90-54.247.23191.4913.00
   EPS Growth(%)139.90-57.230.94191.5112.99
Financial Stability Ratios
   Total Debt/Equity(x)0.030.030.030.040.04
   Current Ratio(x)2.392.511.681.311.06
   Quick Ratio(x)1.771.791.040.860.66
   Interest Cover(x)43.4532.8352.7553.7120.05
   Total Debt/Mcap(x)0.010.020.010.010.03

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.